![Andreas Schmiede](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Schmiede
Corporate Officer/Principal en
MEDIOS AG
.
Perfil
Andreas Schmiede is currently Vice President-Advanced Therapies at Medios AG since 2024.
Formerly, Dr. Schmiede was Head-Business Development Cell & Gene Therapy at Lonza Cologne GmbH.
Cargos activos de Andreas Schmiede
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIOS AG | Corporate Officer/Principal | 05/08/2024 |
Antiguos cargos conocidos de Andreas Schmiede.
| Empresas | Cargo | Fin |
|---|---|---|
Lonza Cologne GmbH
 Lonza Cologne GmbH BiotechnologyHealth Technology Provides biotechnological research and development services | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Medios AG
 Medios AG Medical DistributorsDistribution Services Engages in trading specialty pharmaceutical drugs | Distribution Services |
Lonza Cologne GmbH
Lonza Cologne GmbH BiotechnologyHealth Technology Provides biotechnological research and development services | Health Technology |
- Bolsa de valores
- Insiders
- Andreas Schmiede
